Matrizyme

Photos

Description

Matrizyme Pharma MZ-004 therapy for angioplasty in patients with CTO

Matrizyme Pharma Corporation has developed MZ-004, an innovative therapy to facilitate angioplasty in patients suffering from Chronic Total Occlusions. These 100% complete blockages of an artery represent a significant under-served market due to their complexity and high rate of treatment failure.

Contacts

Phone
+19057710333

Address:
65 West Beaver Creek Rd, Richmond Hill, ON L4B 1K4

Website:
https://www.matrizyme.com/